634 related articles for article (PubMed ID: 15845914)
1. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
Davis SR; Dinatale I; Rivera-Woll L; Davison S
J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
[TBL] [Abstract][Full Text] [Related]
2. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
4. [Menopause and hormone replacement therapy].
Tóth KS
Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
[TBL] [Abstract][Full Text] [Related]
5. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
Genazzani AR; Schneider HP; Panay N; Nijland EA
Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
[TBL] [Abstract][Full Text] [Related]
6. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
7. Justification for the use of HRT in the long-term prevention of osteoporosis.
Stevenson JC
Maturitas; 2005 Jun; 51(2):113-26. PubMed ID: 15917151
[TBL] [Abstract][Full Text] [Related]
8. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
9. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
Wang PH; Horng HC; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
[TBL] [Abstract][Full Text] [Related]
10. Is there a place for postmenopausal hormone therapy use in women with lupus?
Gompel A; Piette JC
Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
[TBL] [Abstract][Full Text] [Related]
11. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
[TBL] [Abstract][Full Text] [Related]
12. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
L'hermite M; Simoncini T; Fuller S; Genazzani AR
Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
[TBL] [Abstract][Full Text] [Related]
13. Use of alternatives to estrogen for treatment of menopause.
Pinkerton JV; Santen R
Minerva Endocrinol; 2002 Mar; 27(1):21-41. PubMed ID: 11845111
[TBL] [Abstract][Full Text] [Related]
14. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
Col NF; Bowlby LA; McGarry K
Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
[TBL] [Abstract][Full Text] [Related]
15. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.
Gastel B; Cornoni-Huntley J; Brody JA
J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387
[TBL] [Abstract][Full Text] [Related]
16. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
Vessey MP
Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy and breast cancer risk.
Foidart JM; Desreux J; Pintiaux A; Gompel A
Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
[TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy and cancer].
Bjørge T; Tropé C
Tidsskr Nor Laegeforen; 1997 Jun; 117(15):2201-7. PubMed ID: 9235712
[TBL] [Abstract][Full Text] [Related]
19. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
20. Hormone therapy--weighing up the evidence.
Teede HJ
Aust Fam Physician; 2004 Nov; 33(11):875-80. PubMed ID: 15584324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]